Back to resultsRandomized Trial of Trust in Online Videos About Prostate Cancer
Primary Purpose
Prostate Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Black Doctor Screening Video
White Doctor Screening Video
Black Patient Screening Video
White Patient Screening Video
Black Doctor Clinical Trials Video
White Doctor Clinical Trials Video
Black Patient Clinical Trials Video
White Patient Clinical Trials Video
Sponsored by
About this trial
This is an interventional other trial for Prostate Cancer focused on measuring Trust
Eligibility Criteria
Inclusion Criteria: US adult age 40+ Enrolled in Dynata online survey panel Exclusion Criteria: Children Individuals living outside the U.S.
Sites / Locations
- NYU Langone Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm Type
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Arm Label
Video About Screening with Black Doctor
Video About Screening with White Doctor
Video About Screening with Black Patient
Video About Screening with White Patient
Video about Clinical Trials with Black Doctor
Video about Clinical Trials with White Doctor
Video about Clinical Trials with Black Patient
Video about Clinical Trials with White Patient
Arm Description
Outcomes
Primary Outcome Measures
Level of Trust in the Video
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05886751
Brief Title
Randomized Trial of Trust in Online Videos About Prostate Cancer
Official Title
Randomized Trial of Trust in Online Videos About Prostate Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
August 18, 2021 (Actual)
Primary Completion Date
January 7, 2022 (Actual)
Study Completion Date
January 7, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos. Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
Trust
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3649 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Video About Screening with Black Doctor
Arm Type
Experimental
Arm Title
Video About Screening with White Doctor
Arm Type
Experimental
Arm Title
Video About Screening with Black Patient
Arm Type
Experimental
Arm Title
Video About Screening with White Patient
Arm Type
Experimental
Arm Title
Video about Clinical Trials with Black Doctor
Arm Type
Experimental
Arm Title
Video about Clinical Trials with White Doctor
Arm Type
Experimental
Arm Title
Video about Clinical Trials with Black Patient
Arm Type
Experimental
Arm Title
Video about Clinical Trials with White Patient
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Black Doctor Screening Video
Intervention Description
Participants will view an online video with a Black doctor speaking about prostate cancer screening.
Intervention Type
Other
Intervention Name(s)
White Doctor Screening Video
Intervention Description
Participants will view an online video with a White doctor speaking about prostate cancer screening.
Intervention Type
Other
Intervention Name(s)
Black Patient Screening Video
Intervention Description
Participants will view an online video with a Black patient speaking about prostate cancer screening.
Intervention Type
Other
Intervention Name(s)
White Patient Screening Video
Intervention Description
Participants will view an online video with a White patient speaking about prostate cancer screening.
Intervention Type
Other
Intervention Name(s)
Black Doctor Clinical Trials Video
Intervention Description
Participants will view an online video with a Black doctor speaking about prostate cancer clinical trials.
Intervention Type
Other
Intervention Name(s)
White Doctor Clinical Trials Video
Intervention Description
Participants will view an online video with a White doctor speaking about prostate cancer clinical trials.
Intervention Type
Other
Intervention Name(s)
Black Patient Clinical Trials Video
Intervention Description
Participants will view an online video with a Black patient speaking about prostate cancer clinical trials.
Intervention Type
Other
Intervention Name(s)
White Patient Clinical Trials Video
Intervention Description
Participants will view an online video with a White patient speaking about prostate cancer clinical trials.
Primary Outcome Measure Information:
Title
Level of Trust in the Video
Description
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video? The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
Time Frame
Visit 1 (Day 1)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
US adult age 40+
Enrolled in Dynata online survey panel
Exclusion Criteria:
Children
Individuals living outside the U.S.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stacy Loeb, MD, MSc, PhD(hc)
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data needed for the proposed biomedical research use according to data use agreement from both parties will be shared.
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
IPD Sharing Access Criteria
The investigator who proposed to use the data after signing a data use agreement will have access to the data upon reasonable request for biomedical research purposes. Requests should be directed to stacy.loeb@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Learn more about this trial
Randomized Trial of Trust in Online Videos About Prostate Cancer
We'll reach out to this number within 24 hrs